Waystar Holding Corp

Waystar Holding Corp (WAY) Stock Analysis

$26.240

+1.029 (+3.92%)At close

Loading chart…
High
26.870
Open
25.440
VWAP
26.17
Vol
1.99M
Mkt Cap
Low
25.415
Amount
52.05M
EV/EBITDA, TTM
12.11

Waystar Holding Corp. provides healthcare organizations with mission-critical cloud software that simplifies healthcare payments. The Company’s enterprise-grade platform, Waystar, streamlines the complex processes. It leverages internally developed artificial intelligence (AI) as well as proprietary, advanced algorithms to automate payment-related workflow tasks and drive continuous improvement, which enhances claim and billing accuracy, enriches data integrity, and reduces labor costs for providers. Its software is used daily by providers of all types and sizes across the continuum of care, including physician practices, clinics, surgical centers, and laboratories, as well as large hospitals and health systems. The Company’s clients utilize its software to manage pre-encounter workflows, such as eligibility checks and prior authorization approvals, as well as mid- and post-encounter workflows, such as co-pay collection, claims submission and monitoring, and payer remittances.

AI analysis of Waystar Holding Corp (WAY)

buy

Waystar Holding Corp is a good buy right now due to its strong earnings performance and positive growth outlook. The current price is $26.24, with a recent RSI of 72.485 indicating strong momentum. The company reported Q2 2026 revenue of $320 million, reflecting an 18% year-over-year growth, and has raised its FY2026 revenue guidance to between $1.276 billion and $1.294 billion, showcasing confidence in future performance. However, a key risk is the insider selling, which has increased by 280.05% over the last month, suggesting potential concerns among insiders.

Valuation Metrics

The current forward P/E ratio for Waystar Holding Corp (WAY) is 14.43, compared to its 5-year average forward P/E of 29.53.

Forward P/E

Undervalued
5Y Average P/E
29.53
Current P/E
14.43
Overvalued
41.55
Undervalued
17.50

Forward EV/EBITDA

Undervalued
5Y Average EV/EBITDA
15.43
Current EV/EBITDA
12.11
Overvalued
18.73
Undervalued
12.13

Forward P/S

Undervalued
5Y Average P/S
4.92
Current P/S
3.26
Overvalued
6.32
Undervalued
3.52

Whales holding WAY

B

Burgundy Asset Management Ltd.

+ HoldingWAY

+11.17%

3M Return

J

Jaunty Global Limited

+ HoldingWAY

+4.05%

3M Return

P

PointState Capital LP

+ HoldingWAY

+2.45%

3M Return

Events Timeline

2026-08-25 (ET)

19:00:00

Waystar Appoints New Chief Product Officer and Chief Commercial Officer

2026-07-29 (ET)

16:31:00

FY26 Revenue Expected Between $1.276B and $1.294B

16:30:00

Waystar Appoints Alpana Wegner as CFO

2026-05-19 (ET)

12:10:00

Waystar Stock Rises 7.0% to $19.84

10:10:00

Waystar Stock Rises 7.7% to $19.97

News

WAY FAQ — answered by Alphio AI

Waystar Holding Corp. provides healthcare organizations with mission-critical cloud software that simplifies healthcare payments. The Company’s enterprise-grade platform, Waystar, streamlines the complex processes. It leverages internally developed artificial intelligence (AI) as well as proprietary, advanced algorithms to automate payment-related workflow tasks and drive continuous improvement, which enhances claim and billing accuracy, enriches data integrity, and reduces labor costs for providers. Its software is used daily by providers of all types and sizes across the continuum of care, including physician practices, clinics, surgical centers, and laboratories, as well as large hospitals and health systems. The Company’s clients utilize its software to manage pre-encounter workflows, such as eligibility checks and prior authorization approvals, as well as mid- and post-encounter workflows, such as co-pay collection, claims submission and monitoring, and payer remittances. It operates in the Technology sector (COMPUTER INTEGRATED SYSTEMS DESIGN industry).

Waystar Holding Corp is a good buy right now due to its strong earnings performance and positive growth outlook. The current price is $26.24, with a recent RSI of 72.485 indicating strong momentum. The company reported Q2 2026 revenue of $320 million, reflecting an 18% year-over-year growth, and has raised its FY2026 revenue guidance to between $1.276 billion and $1.294 billion, showcasing confidence in future performance. However, a key risk is the insider selling, which has increased by 280.05% over the last month, suggesting potential concerns among insiders.

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

無料で始める